New England Journal of Medicine

Q&A: Cancer care in crisis

Almost daily, consumers hear about new advances in the treatment of cancer: a new drug, dazzling technological achievements or eye-opening scientific discoveries. Why, then, are some of the nation's foremost ...

May 01, 2014
popularity not rated yet | comments 0

Biotech to the rescue

MIT professor Ram Sasisekharan's three biotech companies—Momenta Pharmaceuticals, Cerulean Pharma, and Visterra—share a similar goal. "It's about the impact we can have on patient care," says Sasisekharan, ...

Apr 28, 2014
popularity 4 / 5 (2) | comments 0